While the precise tumorigenic mechanisms of ILT4 are unclear, preliminary data indicate that the inhibition of ILT4 induces a shift from anti-inflammatory M2 macrophages towards pro-inflammatory M1 macrophages in the tumor microenvironment [170,171]. Here, LILRB2 is linked to neoplasm.